Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease
Achieving normal growth is one of the most challenging problems in the management of children with chronic kidney disease (CKD). Treatment with recombinant human growth hormone (GH) promotes longitudinal growth and likely enables children with CKD and short stature to reach normal adult height. Here...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 June 2019
|
| In: |
Nature reviews. Nephrology
Year: 2019, Volume: 15, Issue: 9, Pages: 577-589 |
| ISSN: | 1759-507X |
| DOI: | 10.1038/s41581-019-0161-4 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41581-019-0161-4 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41581-019-0161-4 
|
| Author Notes: | Jens Drube, Mandy Wan, Marjolein Bonthuis, Elke Wühl, Justine Bacchetta, Fernando Santos, Ryszard Grenda, Alberto Edefonti, Jerome Harambat, Rukshana Shroff, Burkhard Tönshoff, and Dieter Haffner, on behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1742298184 | ||
| 003 | DE-627 | ||
| 005 | 20230428160827.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201208s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41581-019-0161-4 |2 doi | |
| 035 | |a (DE-627)1742298184 | ||
| 035 | |a (DE-599)KXP1742298184 | ||
| 035 | |a (OCoLC)1341383178 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Drube, Jens |d 1973- |e VerfasserIn |0 (DE-588)1013218477 |0 (DE-627)663822297 |0 (DE-576)34671415X |4 aut | |
| 245 | 1 | 0 | |a Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease |c Jens Drube, Mandy Wan, Marjolein Bonthuis, Elke Wühl, Justine Bacchetta, Fernando Santos, Ryszard Grenda, Alberto Edefonti, Jerome Harambat, Rukshana Shroff, Burkhard Tönshoff, and Dieter Haffner, on behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups |
| 264 | 1 | |c 13 June 2019 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.12.2020 | ||
| 520 | |a Achieving normal growth is one of the most challenging problems in the management of children with chronic kidney disease (CKD). Treatment with recombinant human growth hormone (GH) promotes longitudinal growth and likely enables children with CKD and short stature to reach normal adult height. Here, members of the European Society for Paediatric Nephrology (ESPN) CKD-Mineral and Bone Disorder (MBD), Dialysis and Transplantation working groups present clinical practice recommendations for the use of GH in children with CKD on dialysis and after renal transplantation. These recommendations have been developed with input from an external advisory group of paediatric endocrinologists, paediatric nephrologists and patient representatives. We recommend that children with stage 3-5 CKD or on dialysis should be candidates for GH therapy if they have persistent growth failure, defined as a height below the third percentile for age and sex and a height velocity below the twenty-fifth percentile, once other potentially treatable risk factors for growth failure have been adequately addressed and provided the child has growth potential. In children who have received a kidney transplant and fulfil the above growth criteria, we recommend initiation of GH therapy 1 year after transplantation if spontaneous catch-up growth does not occur and steroid-free immunosuppression is not a feasible option. GH should be given at dosages of 0.045-0.05 mg/kg per day by daily subcutaneous injections until the patient has reached their final height or until renal transplantation. In addition to providing treatment recommendations, a cost-effectiveness analysis is provided that might help guide decision-making. | ||
| 700 | 1 | |a Wan, Mandy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bonthuis, Marjolein |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wühl, Elke |e VerfasserIn |0 (DE-588)1069939617 |0 (DE-627)823052052 |0 (DE-576)429626134 |4 aut | |
| 700 | 1 | |a Bacchetta, Justine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Santos, Fernando |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grenda, Ryszard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Edefonti, Alberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Harambat, Jerome |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shroff, Rukshana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tönshoff, Burkhard |e VerfasserIn |0 (DE-588)1032445823 |0 (DE-627)738463493 |0 (DE-576)173494196 |4 aut | |
| 700 | 1 | |a Haffner, Dieter |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Nephrology |d Basingstoke : Nature Publishing Group, 2009 |g 15(2019), 9, Seite 577-589 |h Online-Ressource |w (DE-627)598094784 |w (DE-600)2490368-1 |w (DE-576)327495782 |x 1759-507X |7 nnas |a Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease |
| 773 | 1 | 8 | |g volume:15 |g year:2019 |g number:9 |g pages:577-589 |g extent:13 |a Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41581-019-0161-4 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41581-019-0161-4 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201208 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1032445823 |a Tönshoff, Burkhard |m 1032445823:Tönshoff, Burkhard |d 910000 |d 910500 |e 910000PT1032445823 |e 910500PT1032445823 |k 0/910000/ |k 1/910000/910500/ |p 11 | ||
| 998 | |g 1069939617 |a Wühl, Elke |m 1069939617:Wühl, Elke |d 910000 |d 910500 |e 910000PW1069939617 |e 910500PW1069939617 |k 0/910000/ |k 1/910000/910500/ |p 4 | ||
| 999 | |a KXP-PPN1742298184 |e 3819323880 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1742298184","id":{"doi":["10.1038/s41581-019-0161-4"],"eki":["1742298184"]},"title":[{"title":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease","title_sort":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease"}],"note":["Gesehen am 08.12.2020"],"person":[{"roleDisplay":"VerfasserIn","family":"Drube","role":"aut","display":"Drube, Jens","given":"Jens"},{"given":"Mandy","display":"Wan, Mandy","role":"aut","roleDisplay":"VerfasserIn","family":"Wan"},{"family":"Bonthuis","roleDisplay":"VerfasserIn","given":"Marjolein","display":"Bonthuis, Marjolein","role":"aut"},{"display":"Wühl, Elke","role":"aut","given":"Elke","family":"Wühl","roleDisplay":"VerfasserIn"},{"display":"Bacchetta, Justine","role":"aut","given":"Justine","roleDisplay":"VerfasserIn","family":"Bacchetta"},{"family":"Santos","roleDisplay":"VerfasserIn","display":"Santos, Fernando","role":"aut","given":"Fernando"},{"family":"Grenda","roleDisplay":"VerfasserIn","display":"Grenda, Ryszard","role":"aut","given":"Ryszard"},{"given":"Alberto","display":"Edefonti, Alberto","role":"aut","family":"Edefonti","roleDisplay":"VerfasserIn"},{"display":"Harambat, Jerome","role":"aut","given":"Jerome","roleDisplay":"VerfasserIn","family":"Harambat"},{"roleDisplay":"VerfasserIn","family":"Shroff","given":"Rukshana","role":"aut","display":"Shroff, Rukshana"},{"roleDisplay":"VerfasserIn","family":"Tönshoff","given":"Burkhard","role":"aut","display":"Tönshoff, Burkhard"},{"given":"Dieter","display":"Haffner, Dieter","role":"aut","family":"Haffner","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Jens Drube, Mandy Wan, Marjolein Bonthuis, Elke Wühl, Justine Bacchetta, Fernando Santos, Ryszard Grenda, Alberto Edefonti, Jerome Harambat, Rukshana Shroff, Burkhard Tönshoff, and Dieter Haffner, on behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups"]},"relHost":[{"title":[{"title_sort":"Nature reviews","title":"Nature reviews","partname":"Nephrology"}],"id":{"issn":["1759-507X"],"zdb":["2490368-1"],"eki":["598094784"]},"disp":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney diseaseNature reviews. Nephrology","note":["Gesehen am 09.03.2021"],"origin":[{"publisher":"Nature Publishing Group","dateIssuedDisp":"2009-","publisherPlace":"Basingstoke","dateIssuedKey":"2009"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2019","extent":"13","pages":"577-589","text":"15(2019), 9, Seite 577-589","issue":"9","volume":"15"},"recId":"598094784","pubHistory":["5.2009,4 -"],"titleAlt":[{"title":"Nature reviews / Nephrology"},{"title":"Nephrology"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"13 June 2019"}],"language":["eng"]} | ||
| SRT | |a DRUBEJENSWCLINICALPR1320 | ||